Skip to main navigation
Skip to search
Skip to main content
The Capital Region of Denmark's Research Portal Home
Dansk
English
Search content at The Capital Region of Denmark's Research Portal
Home
Hospitals/Departments
Researchers
Research output
Activities
Prizes
Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome
Palle Bekker Jeppesen
105
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Glucagon Like Peptide 2
100%
Patient with Short Bowel Syndrome
100%
Teduglutide
100%
Diarrhea
66%
Intestinal Failure
50%
Quality of Life
33%
Congenital Disorder
33%
Short Bowel Syndrome
33%
Intestine Absorption
33%
Placebo
16%
Base
16%
Infection
16%
Thrombosis
16%
Liver Disease
16%
Stomach Emptying
16%
Stomach Secretion
16%
Pedialyte
16%
Malabsorption
16%
Antidiarrheal Agent
16%
Metabolic Balance
16%
Oral
16%
Keyphrases
Intestinal Rehabilitation Program
16%